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Abstract: Stable suspensions of NiO and Mn3O4 nanoparticles (NPs) with a mean (±s.d.) 
diameter of 16.7 ± 8.2 and 18.4 ± 5.4 nm, respectively, purposefully prepared by laser 
ablation of 99.99% pure nickel or manganese in de-ionized water, were repeatedly injected 
intraperitoneally (IP) to rats at a dose of 2.5 mg/kg 3 times a week up to 18 injections, 
either alone or in combination. A group of rats was injected with this combination with the 
background oral administration of a “bio-protective complex” (BPC) comprising pectin, 
vitamins A, C, E, glutamate, glycine, N-acetylcysteine, selenium, iodide and omega-3 
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PUFA, this composition having been chosen based on mechanistic considerations and 
previous experience. After the termination of injections, many functional and biochemical 
indices and histopathological features (with morphometric assessment) of the liver, spleen, 
kidneys and brain were evaluated for signs of toxicity. The Ni and Mn content of these organs 
was measured with the help of the atomic emission and electron paramagnetic resonance 
spectroscopies. We obtained blood leukocytes for performing the RAPD (Random Amplified 
Polymorphic DNA) test. Although both metallic NPs proved adversely bio-active in many 
respects considered in this study, Mn3O4-NPs were somewhat more noxious than NiO-NPs 
as concerns most of the non-specific toxicity manifestations and they induced more marked 
damage to neurons in the striatum and the hippocampus, which may be considered an 
experimental correlate of the manganese-induced Parkinsonism. The comparative solubility 
of the Mn3O4-NPs and NiO-NPs in a biological medium is discussed as one of the  
factors underlying the difference in their toxicokinetics and toxicities. The BPC has 
attenuated both the organ-systemic toxicity and the genotoxicity of Mn3O4-NPs in 
combination with NiO-NPs. 
Keywords: nanoparticles; manganese(II, III) oxide; nickel(II) oxide; subchronic toxicity; 
bioprotectors 
 
1. Introduction 
Nanoparticles (NPs) of metal oxides are of special interest for industrial toxicology and for 
occupational health risk assessment and management not only because there exists a number of 
purposefully manufactured (engineered) NPs of this class but also because they constitute a substantial 
proportion within the particle size distribution of the condensation aerosols generated by arc-welding 
and various metallurgical technologies. Indeed, such aerosols commonly include, along with 
chemically similar fine micrometer particles and submicron ones having dimensions >100 nm, the 
conventional nanoscale fraction (<100 nm). 
The prevailing majority of the published studies have assessed the cytotoxicity and genotoxicity of 
NPs on stable cell lines and only rarely on laboratory animals. No doubt, in vitro experiments feature a 
number of advantages, in particular, relating to analysis of primary mechanisms of toxicity. However, 
any extrapolation of such experimental results to the whole mammalian organism is associated with a 
number of uncertainties and assumptions. Moreover, some important aspects of toxicology (in particular, 
toxicokinetics, dose-response relationships on organ and systemic levels, and the functioning of protective 
mechanisms) can generally be addressed only through experiments on a whole mammalian organism. 
We have demonstrated just in such experiments that several metallic NPs are much more toxic on 
both in vivo cellular and systemic levels as compared with their one micrometer or even submicron 
counterparts, while the dependence of systemic toxicity on particle size within the nanometer range is 
non-unique due to often contra-directional relationships between the intrinsic cytotoxicity of specific 
nanoparticles, on the one hand, and mechanisms that control their biokinetics, on the other [1–4]. 
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As a rule, however, the industrial aerosols generated by the above technologies (arc-welding and 
alloyed steel metallurgy especially) not only are polydisperse but also have a complex chemical 
composition comprising microparticles and nanoparticles of oxides of iron, manganese, nickel, 
chrome, vanadium, silicon and other elements. Both the composition of these NPs and quantitative 
relationships between them vary broadly depending on specific technology, its phase, composition of 
the molted metal, melting temperature, etc. One of the distinctive features of industrial nanotoxicology 
is, therefore, the frequent need to carry out not only separate but also comparative assessments of the 
toxicities of various metal oxide NPs, as well as of their combined effects. Particularly important are 
the manifestations of organ and systemic toxicity that are associated not only with the general 
mechanisms of the cytotoxic effect produced by NPs, which are very actively studied by various 
researchers at subcellular and cellular levels [5] focusing on the generation of reactive oxygen species 
and on intracellular release of metal ions, but also with the ones that are more or less specific to the 
toxicokinetics and toxicodynamics of certain metals. 
It should not go unmentioned that the literature reports (to the best of our knowledge) very few 
comparative qualitative assessments of the effects exerted on the organism by chemically different 
NPs in parallel chronic or, at least, subchronic experiments in vivo for similar particle doses, shapes 
and sizes. We carried out a study that met these conditions for NPs of gold and silver [6]. However, it 
was planned not because these NPs occur in any industry and thus impact on the human organism in 
combination but, rather, because it was not yet quite clear theoretically which characteristics of 
nanomaterials play the most important role: those associated with the nano-dimension of particles of 
any chemical composition or those determined by the chemical nature of the NP-forming substance. 
The results of that study suggest that both characteristics, dimension and chemistry, are essential. If 
this is the case, the higher is the practical importance of the toxic effects produced by metal oxide NPs 
that are actually present in one and the same industrial environment. 
In the context of this issue, we have chosen NPs of nickel and manganese oxides, which are often 
present together both in the workplace and ambient air of steel-making facilities and in welding fumes [7]. 
Nickel is usually present in the form of nickel(II) oxide (NiO-NPs), and manganese as a great number 
of oxygen compounds, one of which is manganese(II, III) oxide (Mn3O4-NPs) [8–10]. Experimental 
assessments of the toxicity of various nickel- and manganese-containing NPs, carried out on cell 
cultures or under intratracheal instillations, have been reported by various researchers [11–18], but,  
as far as we know, no comparative assessment has ever been carried out in a parallel subchronic 
experiment in vivo. 
The toxic properties of various manganese and nickel oxides and salts in the form of solutions and 
microparticles acting alone have been extensively investigated [19–21]. Subchronic intoxication of rats 
with NiСl2 and KMnO4 acting together was characterized by different types of combined toxicity 
(either of additive type or departing from it predominantly towards subadditivity) depending on the 
effect assessed, dose, and effect level [22]. 
This paper, however, is focused mainly on another important but rarely considered aspect of metal 
nanotoxicology. We maintain that the especially high toxicity of metallic NPs calls for searching for 
some means to render exposed people more resistant to their adverse effects. The general concept of 
such “biological prophylaxis” of different occupational and environmental intoxications, its theoretical 
premises and general principles along with numerous examples of its practical realization have been 
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published by us over several decades repeatedly, including in review articles [23,24]. It was but natural 
to explore the potential of such preventive strategy in the field of nanotoxicology as well. 
Our previous experiments proved that both systemic toxicity and in vivo genotoxicity of silver [6] and of 
copper oxide [4] NPs were markedly attenuated with background oral administration of multi-component 
bioprotective complexes (BPC). These BPCs comprised pectin, multivitamin-multimineral preparations, 
some amino acids, and omega-3 PUFA. In both cases the protective action was demonstrated in relation to 
various adverse effects of subchronic toxicity. We also found [25] that in rats that were being given 
glutamate, glycine, N-acetyl cysteine, iodide and a Se-containing multivitamin preparation orally 
during 4 weeks before a single intratracheal instillation of NiO-NPs + Mn3O4-NPs (0.25 mg each), the 
latter evoked significantly weaker neutrophil leukocyte recruitment into the lower airways than in rats 
so exposed without any pretreatment. Now we are able to demonstrate the preventive efficacy of  
a bio-protective complex administered also orally but along with repeated i.p. injections of a similar 
combination of NPs. 
Table 1. Total manganese and nickel contents of rat’s organs, mcg per g of dried tissue, after 
repeated intraperitoneal injections of NiO or Mn3O4 nanoparticles, together or separately, 
and of their combination with background oral administration of the BPC (X ± s.e.). 
Metal 
Groups of Rats Given (6 Rats) 
Control NiO-NPs Mn3O4-NPs 
NiO-NPs +  
Mn3O4-NPs 
NiO-NPs +  
Mn3O4-NPs and BPC
Liver 
Manganese 7.33 ± 0.56 6.33 ± 0.49 7.20 ± 0.73 6.80 ± 0.20 7.17 ± 0.31 
Nickel 3.17 ± 0.65 16.40 ± 3.26 *,+,○ 2.80 ± 0.20 + 38.00 ± 2.80 * 18.50 ± 1.56 *,+ 
Spleen 
Manganese 28.80 ± 1.74 32.00 ± 4.15 25.00 ± 1.87 25.83 ± 4.23 14.00 ± 2.33 *,+ 
Nickel 25.60 ± 1.89 46.75 ± 8.44 * 32.50 ± 4.63 36.17 ± 7.21 36.25 ± 8.97 
Kidneys 
Manganese 13.75 ± 0.95 10.00 ± 0.63 *,○ 20.50 ± 1.45 *,+ 10.80 ± 1.11 16.17 ± 1.62 + 
Nickel 18.20 ± 1.56 20.60 ± 3.23 16.00 ± 1.58 17.60 ± 1.29 18.67 ± 1.28 
Brain 
Manganese 6.00 ± 0.45 7.17 ± 0.98 10.75 ± 1.70 * 7.60 ± 1.08 9.20 ± 0.80 * 
Nickel 14.67 ± 0.96 12.83 ± 1.20 15.75 ± 2.46 15.80 ± 2.65 8.60 ± 0.60 + 
* statistically significant difference from the control group; + from the group given NiO-NPs + Mn3O4-NPs 
(without the BPC); ○ from the group given Mn3O4-NPs; (p < 0.05 by Student’s t-test with Bonferroni correction). 
2. Results 
As can be seen from Table 1, the total Ni content (as determined by AES) was significantly 
increased under exposure to both NiO-NPs and NiO-NPs + Mn3O4-NPs in the liver and spleen only. 
Exposure to Mn3O4-NPs injected alone (not in combination with NiO-NPs) induced a noticeable 
increase in the Mn content of the kidneys and brain only. Meantime, the accumulation of Ni in the 
liver of the rats given this combination was significantly higher as compared with those exposed to 
NiO-NPs alone. This increase was not present in the group with background BPC administration, and 
the Ni content of the liver in this group proved 2 times lower (p < 0.05) as compared with the group 
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exposed to NPs of NiO-NPs + Mn3O4-NPs without the BPC. Under the influence of the BPC, the 
accumulation of manganese in the spleen and nickel in the brain decreased significantly while the 
same BPC increased nickel accumulation in the kidneys. 
Both NiO and Mn3O4 (and, thus, respective NPs) were detected with the help of EPR spectroscopy 
in the liver and spleen only, while the EPR signal of the Mn3O4-NPs was too weak for quantification. 
As for the NiO-NPs content (Figure 1), it was somewhat lower, rather than higher (unlike the total Ni 
content), in the combined exposure group compared with the group exposed to NiO-NPs alone, and 
again, this content was decreased by BPC administration. 
 
Figure 1. Nickel (as NiO-NPs) content of the liver and spleen in the groups of rats exposed 
to NiO-NPs, to Mn3O4-NPs + NiO-NPs, or to the same combination together with the BPC 
(designated as NiO-NPs, Mn + Ni and Me + BPC, respectively). Electron paramagnetic 
resonance (EPR) method. Dots correspond to arithmetic means; bars, to 95% CI. 
As can be seen from Table 2, in the rats exposed to NiO-NPs the daily renal excretion of Ni was 
statistically significantly increased. The respective increase in the rats exposed to NiO-NPs + Mn3O4-NPs 
was also significant but half as high compared with those exposed to NiO-NPs only (p < 0.05),  
while in the rats similarly exposed to NiO-NPs + Mn3O4-NPs along with BPC administration it did  
not differ from the value for the NiO-NPs-exposed ones. At the same time, exposure to Mn3O4-NPs 
increased manganese excretion only when combined with exposure to NiO-NPs, but this increase was 
not significant in the rats administered the BPC. 
Table 2. Total manganese and nickel renal excretion in rats after repeated intraperitoneal 
injections of NiO or Mn3O4 nanoparticles, together or separately, and of their combination 
with background oral administration of the BPC, mcg per 24 h (X ± s.e.). 
Metal 
Groups of Rats Given  
Control  
(7 Rats) 
NiO-NPs  
(8 Rats) 
Mn3O4-NPs 
(8 Rats) 
NiO-NPs +  
Mn3O4-NPs (7 Rats) 
NiO-NPs + Mn3O4-NPs and  
BPC (7 Rats) 
BPC  
(7 Rats) 
Manganese 0.06 ± 0.05 0.008 ± 0.006 + 0.06 ± 0.01 + 0.52 ± 0.1 * 0.28 ± 0.1 0.11 ± 0.1 
Nickel 2.9 ± 0.2 37.9 ± 5.3 *,+,○ 0.63 ± 0.3 *,+ 16.7 ± 2.9 * 40.8 ± 6.2 *,+ 3.2 ± 0.3 
* statistically significant difference from the control group; + from the group given NiO-NPs + Mn3O4-NPs 
(without the BPC); ○ from the group given Mn3O4-NPs; (p < 0.05 by Student’s t-test with Bonferroni correction). 
Out of the 50 functional and biochemical indices for the organism’s status given in Table 3, a 
statistically significant adverse deviation from the control value was observed in 22 indices for the 
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effect of NiO-NPs, in 26 for the effect of Mn3O4-NPs, in 25 for the combined action of the same NPs, 
and in only one under exposure to the same combination with the background BPC administration 
caused deviation in any of the indices, whereas the same administration without toxic exposure caused 
shifts in 6 indices (Table 3). Shifts caused by two nano-oxides under comparison were, as a rule, 
unidirectional and close in magnitude. However, the majority of the indices displayed a somewhat 
higher effect of Mn3O4-NPs than that of NiO-NPs, although in only three of them (increased liver 
mass, reduced number of head-dips, and reduced albumin content of the blood serum) this difference 
was statistically significant. In the case of combined intoxication, the majority of the indices fell within 
the range of values for separate exposures, though tending towards the prevalence of the low values of 
this range. At the same time, diuresis was lowered along with increased density of the urine only for 
the combined effect of the nano-oxides (differing statistically significantly from the index of not only 
the control group but also each of the groups exposed to one of the nano-oxides alone). The same 
combined exposure group displayed the highest protein and creatinine contents of the urine (with a 
statistically significant difference from the corresponding indices of the rats exposed to NiO-NPs alone), 
featuring the least endogenous creatinine clearance (significantly lower than in the group exposed to 
Mn3O4-NPs alone, the only group in which this index was significantly above the control value). 
Table 3. Some functional indices for the condition of rat after repeated intraperitoneal 
injections of NiO or Mn3O4 nanoparticles separately and of their combination with 
background oral administration of the BPC (X ± s.e.). 
Index 
Control  
(10 Rats) 
Mn3O4-NPs  
(11 Rats) 
NiO-NPs  
(11 Rats) 
NiO-NPs +  
Mn3O4-NPs  
(12 Rats) 
NiO-NPs +  
Mn3O4-NPs and BPC  
(12 Rats) 
BPC  
(10 Rats) 
Starting body mass, g 195.0  ± 4.8 207.3 ± 4.9 201.0 ± 3.0 203.2 ± 3.0 200.0 ± 5.9 204.5 ± 5.4 
Final body mass, g 232.5 ± 5.5 243.2 ± 4.6 244.0 ± 2.9 247.3 ± 6.6 238.6 ± 7.6 239.5 ± 5.5 
Body mass gain, % 19.4 ± 2.1 17.5 ± 1.4 21.5 ± 1.3 21.6 ± 2.0 19.4 ± 2.3 17.3 ± 1.4 
Liver mass, g per  
100 g body mass 
3.5 ± 0.1 4.8 ± 0.1 *,+ 4.0 ± 0.1 *,○ 3.9 ± 0.1 3.7 ± 0.2 3.7 ± 0.2 
Spleen mass, g per  
100 g body mass 
0.36 ± 0.01 0.48 ± 0.03 * 0.41 ± 0.02 0.44 ± 0.03 * 0.37 ± 0.03 0.38 ± 0.02 
Kidney mass, g per  
100 g body mass 
0.64 ± 0.01 0.62 ± 0.02 * 0.59 ± 0.01 * 0.59 ± 0.01 * 0.58 ± 0.01 0.64 ± 0.02 
Brain mass, g per  
100 g body mass 
0.76 ± 0.01 0.72 ± 0.01 * 0.72 ± 0.02 0.7 ± 0.02 0.68 ± 0.02 0.77 ± 0.02 
Temporal summation of 
sub-threshold impulses, s. 
15.9 ± 0.6 17.2 ± 1.03 17.6 ± 1.03 16.7 ± 1.0 16.9 ± 0.9 16.9 ± 1.1 
Number of head-dips into 
holes during 3 min 
9.2 ± 0.9 2.3 ± 0.6 *,+ 5.3 ± 1.1 *,○ 6.0 ± 1.0 * 3.3 ± 1.4 * 5.4 ± 1.5 
Hemoglobin, g/dL 14.0 ± 0.4 13.0 ± 0.4 12.6 ± 0.2 * 12.0 ± 0.8 * 13.0 ± 0.4 13.8 ± 0.2 
Erythrocytes, 1012 cells/L 7.8 ± 0.2 5.8 ± 0.2 * 5.8 ± 0.2 * 5.6 ± 0.4 * 6.2 ± 0.2 6.4 ± 0.2 
Average volume of red 
blood cells, µm3 
61.5 ± 1.0 65.9 ± 1.0 * 64.6 ± 1.0 * 64.9 ± 1.0 * 61.8 ± 0.9 + 65.9 ± 0.8 * 
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Table 3. Cont. 
Index 
Control  
(10 Rats) 
Mn3O4-NPs  
(11 Rats) 
NiO-NPs  
(11 Rats) 
NiO-NPs +  
Mn3O4-NPs  
(12 Rats) 
NiO-NPs +  
Mn3O4-NPs and BPC  
(12 Rats) 
BPC  
(10 Rats) 
Hematocrit, % 42.6 ± 0.6 38.4 ± 1.2 * 37.8 ± 1.0 * 36.6 ± 1.0 * 39.4 ± 1.0 41.4 ± 1.0 
Reticulocytes, ‰ 21.4  ± 3.1 25.2 ± 3.7 31.1 ± 3.1 * 27.3 ± 3.0 21.5 ± 2.3 17.5 ± 2.3 
Leukocytes, 103/µL 8.6 ± 0.8 10.4 ± 0.6 8.4 ± 0.8 + 12.2 ± 1.0* 11.4 ± 1.2 + 8.6 ± 0.8 
Thrombocytes, 103/µL 735.2 ± 37.6 771.6 ± 41.0 718.2 ± 36.8 802.6  ± 30.2 776.4 ± 39.8 751.4 ± 36.0 
Lymphocytes,% 93.7 ± 1.0 84.5 ± 2.0 *,+ 85.6 ± 2.3 * 90.5 ± 1.5 91.3 ± 1.2 93.2 ± 0.8 
Monocytes,% 4.9 ± 0.9 12.2 ± 1.6 *,+ 11.1 ± 2.0 * 7.7 ± 1.3 7.2 ± 0.9 5.4 ± 0.7 
Granulocytes,% 1.3 ± 0.2 3.3 ± 0.6 *,+ 3.2 ± 0.4 *,+ 1.8 ± 0.3 1.6 ± 0.2 1.4 ± 0.3 
Bilirubin in blood serum, 
μmol/L 2.02 ± 0.4 0.97 ± 0.1 * 1.15 ± 0.1 * 1.15 ± 0.1 * 1.5 ± 0.1 
+ 1.7 ± 0.1 
Succinate dehydrogenase 
(SDH) activity, number 
of formazane granules  
per 50 lymphocytes 
647.1 ± 14.5 551.6 ± 20.6 * 560.7 ± 11.5 * 530.2 ± 22.5 * 569.1 ± 17.6 591.0 ± 11.5 * 
Total protein content of 
blood serum, g/L 
76.0 ± 1.3 75.2 ± 1.7+ 71.2 ± 1.7 * 69.4 ± 1.9 * 72.7 ± 1.2 79.4 ± 1.5 
Albumin content of blood 
serum, g/L 
46.6 ± 0.8 38.3 ± 0.9 * 42.5 ± 1.1 *,+,○ 38.6 ± 0.8 * 41.8 ± 1.1 + 47.3 ± 1.2 
Globulins of blood 
serum, g/L 
29.4 ± 0.9 36.9 ± 1.5 *,+ 28.8 ± 1.6 ○ 30.7 ± 1.4 30.9 ± 0.9 32.1 ± 1.2 
A/G index 1.6 ± 0.06 1.1 ± 0.05 *,+ 1.5 ± 0.1 +,○ 1.3 ± 0.04 * 1.4 ± 0.1 1.5 ± 0.1 
AST activity in blood 
serum, mM/h × L 
378.5 ± 25.7 275.0 ± 25.2 * 279.4 ± 24.6 * 279.0 ± 18.4 * 338.8 ± 43.5 305.8 ± 18.5 * 
ALT activity in blood 
serum, mM/h × L 
75.8 ± 4.8 54.7 ± 4.7 * 55.5 ± 3.3 * 50.5 ± 3.4 * 62.3 ± 6.3 61.0 ± 2.9 * 
De Ritis coefficient 5.01 ± 0.2 5.04 ± 0.2 4.97 ± 0.2 5.68  ± 0.4 5.37 ± 0.3 5.09 ± 0.3 
SH-groups in blood 
serum, µmol/L 
14.9 ± 0.5 18.0 ± 1.4 15.7 ± 0.9 16.6 ± 1.8 12.9 ± 1.7 14.9 ± 1.3 
Uric acid in blood serum, 
µmol/L 
157.0 ± 11.8 116.6 ± 12.2 * 112.5 ± 11.9 * 119.3 ± 7.9 * 143.3 ± 15.9 124.1 ± 6.7 * 
Urea in blood serum, 
mmol/L 
5.4  ± 0.5 5.07 ± 0.6 4.9 ± 0.7 4.6 ± 0.5 5.3 ± 0.5 5.8 ± 0.5 
Activity of  
γ-glutamintransferase in 
blood serum, nmol/(s × L) 
10.6 ± 0.9 8.8 ± 0.8 9.3 ± 1.3 8.1 ± 0.5* 9.05 ± 1.02 12.6 ± 1.3 
Creatinine in blood 
serum, µmol/L 
48.4 ± 1.9 44.6 ± 0.9 46.4 ± 0.9 44.3 ± 1.5 44.2 ± 1.1 48.3 ± 1.3 
Alkaline phosphatase in 
blood serum,  
nmol/(s × L) 
110.7 ± 7.9 131.3 ± 8.9 124.8 ± 4.4 115.2 ± 6.2 115.9 ± 8.7 104.3 ± 10.9 
Catalase in blood serum, 
µmol/L 
1.6 ± 0.1 0.9 ± 0.2 * 1.1 ± 0.1 * 0.96  ± 0.2 * 1.35 ± 0.1 1.6 ± 0.1 
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Table 3. Cont. 
Index 
Control  
(10 Rats) 
Mn3O4-NPs  
(11 Rats) 
NiO-NPs  
(11 Rats) 
NiO-NPs +  
Mn3O4-NPs  
(12 Rats) 
NiO-NPs +  
Mn3O4-NPs and BPC  
(12 Rats) 
BPC  
(10 Rats) 
Reduced glutathione in 
the blood hemolysate, 
µmol/L 
22.6 ± 1.9 18.4 ± 1.1 16.8 ± 1.6 * 22.1 ± 2.6 20.5 ± 1.1 17.8 ± 1.7 
Ceruloplasmin in blood 
serum, mg/% 
71.2 ± 2.9 98.3 ± 6.28 * 100.8 ± 6.3 * 101.3 ± 5.0 * 121.6 ± 9.6 75.6 ± 4.5 
MDA in blood serum, 
nmol/L 
5.21 ± 0.1 4.5 ± 0.2 * 4.9 ± 0.2 4.55 ± 0.2 * 4.49 ± 0.2 4.92 ± 0.3 
Thyrotropic hormone of 
hypophysis in blood 
serum, МЕ/L 
1.15 ± 0.2 1.2 ± 0.2 1.7 ± 0.4 1.5 ± 0.3 0.96 ± 0.4 1.0 ± 0.2 
Thyroxin in blood serum, 
pmol/L 
6.7 ± 0.6 3.8 ± 0.3 *,+ 4.8 ± 0.5 * 4.7 ± 0.4 * 4.6 ± 0.4 4.8 ± 0.2 * 
Triiodothyronine in blood 
serum, pmol/L 
12.8 ± 0.9 14.8 ± 1.6 13.7 ± 1.0 13.7 ± 0.7 13.2 ± 0.7 11.2 ± 0.6 
Diuresis, mL 32.7 ± 1.8 30.0 ± 3.1 + 34.7 ± 3.5 + 17.9  ± 2.9 * 30.2 ± 2.7+ 31.2 ± 4.5 
Urine relative density 1.017 ± 0.001 1.017 ± 0.002 + 1.016 ± 0.001 + 1.023 ± 0.001 * 1.019 ± 0.001 + 1.019 ± 0.001 
Protein in urine, g /L 0.13 ± 0.02 0.15 ± 0.01 0.11 ± 0.01 +,○ 0.19 ± 0.04 0.16 ± 0.03 0.13 ± 0.01 
Urea in urine, mmol/L 146.8 ± 8.4 154.6 ± 8.9 143.3 ± 9.1 183.6 ± 15.3 147.4 ± 8.4 134.2 ± 7.6 
Uric acid in urine, 
µmol/L 
91.8 ± 8.9 138.3 ± 11.4 * 98.4 ± 6.0 +,○ 166.0 ± 19.1 * 116.6 ± 11.9 89.8 ± 6.2 
Creatinine in urine, 
mmol/L 
1.09 ± 0.1 1.4 ± 0.1 * 1.13 ± 0.08 + 1.8 ± 0.2 * 1.2  ± 0.1 + 1.2 ± 0.1 
Endogenous creatinine 
clearance, mL/min 
0.76 ± 0.03 0.90 ± 0.03 *,+ 0.84 ± 0.05 0.66 ± 0.07 0.78 ± 0.04 0.72 ± 0.05 
δ–ALA in urine, µmol/L 6.7 ± 1.6 8.27 ± 1.8 11.9 ± 1.8 9.0 ± 1.5 6.2 ± 0.6 8.4 ± 1.3 
δ–ALA in urine, 
µmol/day 
0.23 ± 0.07 0.29 ± 0.05 0.34 ± 0.08 0.54 ± 0.13 0.22 ± 0.02 + 0.25 ± 0.08 
* statistically significant difference from the control group; + from the group given NiO-NPs + Mn3O4-NPs 
(without the BPC); ○ from the group given Mn3O4-NPs; (p < 0.05 by Student’s t-test with Bonferroni correction). 
It is only in response to the exposure to Mn3O4-NPs, both alone and in combination with NiO-NPs, 
that the concentration of uric acid in the urine was substantially and statistically significantly elevated. 
This effect was the highest in the group exposed to the combination of the NPs (although it was not 
significantly different from the group exposed to Mn3O4-NPs alone), while the exposure to NiO-NPs 
alone did not have any influence on the concentration of uric acid at all. In contrast, the concentration 
of uric acid in the blood serum was significantly reduced compared with the control values in  
all groups with the exception of the one exposed to the combination of Mn3O4-NPs + NiO-NPs with 
BPC administration. 
In the group that was exposed to the same combined impact of Mn3O4-NPs + NiO-NPs while being 
administered the BPC, intoxication, as was noted above, did not manifest itself in a statistically 
significant shift from the control value even if in one index, while in eight of them (average volume of 
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red blood cells, number of leukocytes, bilirubin and albumin contents of the blood serum, diuresis, 
specific density of the urine, creatinine and δ-ALA contents of the urine) the difference of the group 
“Mn3O4-NPs + NiO-NPs + BPC” from the group “Mn3O4-NPs + NiO-NPs” was statistically significant. 
The histological picture (Figures 2–4) and morphometric characteristic (Table 4) of the epithelium 
in the proximal convoluted tubules provide evidence of marked damage, which is a little more marked 
in response to NiO-NPs and, particularly, Mn3O4-NPs + NiO-NPs, than to Mn3O4-NPs alone, but is 
absent for the same combined intoxication with the background administration of the BPC. 
 
Figure 2. Kidney of a control rat (proximal convoluted tubules with an intact brush 
border). Periodic Acid Shiff (PAS) stain, magnification ×400. 
 
Figure 3. Kidney of a rat exposed to nanoparticles of NiO and Mn3O4 together. Marked 
degenerative and necrobiotic changes of tubular epithelial cells up to their disappearance; 
partial destruction of the brush border. PAS stain, magnification ×400. 
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Figure 4. Kidney of a rat exposed to nanoparticles of NiO and Mn3O4 together against the 
background BPC administration. Marked alleviation of tubular damage (compare with 
Figures 2 and 3). PAS stain, magnification ×400. 
Table 4. Morphometric indices for tubular epithelium damage in the kidneys of rats after 
repeated intraperitoneal injections of NiO or Mn3O4 nanoparticles, together or separately, 
and of their combination with background oral administration of the BPC (X ± s.e.). 
Groups of Rats Given 
Brush Border Loss  
(% Lengthwise) 
Epithelial Desquamation 
(% Lengthwise) 
Water (control) (4 rats) 5.44 ± 0.9 0.00 ± 0 
NiO-NPs (4 rats) 10.3 ± 1.7 * 0.48 ± 0.36 
Mn3O4-NPs (4 rats) 9.02 ± 1.17 * 0.28 ± 0.32 + 
NiO-NPs + Mn3O4-NPs (4 rats) 12.33 ± 2.3 * 2.43 ± 1.0 * 
NiO-NPs + Mn3O4-NPs + BPC (4 rats) 7.08 ± 1.7 0.00 ± 0 + 
* statistically significant difference from the control group; + from the group given NiO-NPs + Mn3O4-NPs 
(without the BPC); (p < 0.05 by Student’s t-test with Bonferroni correction). 
The morphometry of the histological liver preparations (Table 5) revealed an increased number of 
akaryotic hepatocytes in all groups exposed to the NPs. However, this effect was neither high nor 
statistically significant in the group under combined exposure to NiO-NPs + Mn3O4-NPs with the BPC 
administered. Neither significant was the difference between the effects of NiO-NPs and Mn3O4-NPs, 
but the combined action of these NPs caused the least increase in the number of akaryotic hepatocytes, 
being statistically significantly different from the effect of NiO-NPs. The increase in the number of 
Kupffer cells was, on the contrary, maximal under the combined impact and statistically significant 
compared not only with the control value but also with the indices for both separate exposures, being 
absent at all under the effect of NiO-NPs. With BPC being administered, this index was in the group 
exposed to NiO-NPs + Mn3O4-NPs not statistically significantly different from the control value and 
statistically significantly lower than in the group of the same combined exposure without BPC 
administration. The number of binucleated hepatocytes was considerably reduced only for the effect of 
NiO-NPs alone. 
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Table 5. Morphometric indices for the state of rat’s liver and spleen after repeated 
intraperitoneal injections of NiO or Mn3O4 nanoparticles, together or separately, and of 
their combination with background oral administration of the BPC (X ± s.e.). 
Indices 
Groups of Rats (4 Rats) 
Control NiO-NPs Mn3O4-NPs 
NiO-NPs + 
Mn3O4-NPs 
Nio-NPs +  
MN3O4-NPs + BPC 
Liver 
Akaryotic hepatocytes  
per 100 liver cells 
2.73 ± 0.28 7.93 ± 0.51 *,+ 6.03 ± 0.42 * 5.43 ± 0.41 * 3.38 ± 0.34 + 
Binucleated hepatocytes  
per 100 liver cells 
17.15 ± 0.66 14.33 ± 0.63 + 18.03 ± 0.60 18.40 ± 0.92 16.20 ± 0.72 
Kupffer cells per 100 liver cells 11.25 ± 0.55 10.20 ± 0.63 + 12.75 ± 0.45 *,+ 16.30 ± 1.22 * 12.2 ± 0.7 + 
Spleen 
Red pulp to white pulp ratio 8.3 ± 1.4 4.5 ± 0.9 * 5.2 ± 1.3 3.6 ± 0.4 * 6.2 ± 1.3 + 
Number of brown pigment 
micro aggregates per square of 
the avtandilov’s grid 
0 2.5 ± 0.2 ○ 6.4 ± 0.3 *,+ 10.4 ± 0.4 * 5.9 ± 0.2 *,+ 
* statistically significant difference from the control group; + from the group given NiO-NPs + Mn3O4-NPs 
(without the BPC); ○ from the group given Mn3O4-NPs; (p < 0.05 by Student’s t-test with Bonferroni correction). 
In the spleen (Table 5), both types of NPs, particularly Mn3O4-NPs and, to even greater extent, the 
combination of Mn3O4-NPs + NiO-NPs caused a decrease of the red pulp to white pulp area ratio and 
an increase in the number of brown pigment microaggregates (which could be identified with Perl’s 
stain as iron-containing). With the BPC being administered, these effects of combined toxic exposure 
were statistically significantly reduced. 
Table 6. Morphometric indices for the state of the rat’s brain after repeated intraperitoneal 
injections of NiO or Mn3O4 nanoparticles, together or separately, and of their combination 
with background oral administration of the BPC (X ± s.e.). 
Neurons  
(%) 
Control  
(4 Rats) 
Mn3O4-NPs  
(4 Rats) 
NiO-NPs  
(4 Rats) 
NiO-NPs + Mn3O4-NPs  
(4 Rats) 
NiO-NPs + Mn3O4-NPs 
and BPC (4 Rats) 
Nucleus caudatus 
Without a nucleolus 30.50 ± 2.77 69.90 ± 1.79 *,+ 47.36 ± 2.45 *,+ 60.30 ± 2.26 * 37.15 ± 2.89 + 
With a distinct centrally  
located nucleolus 
25.12 ± 1.16 9.33 ± 0.90 *,+ 17.00 ± 1.04 *,+ 12.35 ± 0.95 * 23.28 ± 1.09 + 
Hippocampus (CA 1) 
Without a nucleolus 30.50 ± 2.30 70.45 ± 2.31 * 35.8 ± 2.21 + 70.40 ± 3.75 * 41.30 ± 2.14 *,+ 
With a distinct centrally  
located nucleolus 
46.4 ± 2.92 13.4 ± 1.51 * 31.6 ± 1.75 *,+ 11.0 ± 1.13 * 30.5 ± 1.96 *,+ 
* statistically significant difference from the control group; + from the group given NiO-NPs + Mn3O4-NPs 
(without the BPC); (p < 0.05 by Student’s t-test with Bonferroni correction). 
The most prominent and similar pathological changes of brain structures were revealed in the area 
of caudate nucleus and in the СА1 area of the hippocampus; as examples, we give microscopic pictures 
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of the latter in a control rat (Figure 5) and in one exposed to Mn3O4-NPs + NiO-NPs (Figure 6) Both 
morphometric indices of the brain’s histological picture used in our study, namely, counts of neurons 
with completely absent nucleolus and of those with a distinct nucleolus located in the nucleus centre 
show substantial damage to these structures of the brain mostly in the rats exposed to either Mn3O4-NPs 
or Mn3O4-NPs + NiO-NPs. This adverse effect is almost absent in rats exposed to the same toxic 
combination with the background BPC administration (Table 6 and Figure 7). 
 
Figure 5. The brain of a control rat, hippocampus (CA1). Hematoxylin and eosin stain, 
magnification ×400. The neuron nuclei are predominantly spherical with well-visible 
eosinophilic granulosity, and notable nucleoli in the center. 
 
Figure 6. The brain of a rat exposed to nanoparticles of NiO and Mn3O4 together; 
hippocampus (CA1). Hematoxylin and eosin stain, magnification ×400. A lot of neurons 
with marked degenerative changes or pycnosis; in some nuclei the nucleolus is displaced 
or absent. 
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Figure 7. The brain of a rat exposed to nanoparticles of NiO and Mn3O4 together against 
the background BPC administration; hippocampus (CA1). Hematoxylin and eosin stain, 
magnification ×400. Marked alleviation of neuronal damage (compare with Figures 5 and 6). 
The coefficient of genomic DNA fragmentation in the blood nucleated cells (Table 7) proved to be 
statistically significantly and virtually equally elevated in the rats exposed to all the NPs tested, but the 
background BPC administration significantly reduced the effect of the combined toxic exposure while 
the BPC alone did not produce any significant influence on the control value. 
Table 7. The coefficient of genomic DNA fragmentation in the blood nucleated cells of rats 
after repeated intraperitoneal injections of NiO or Mn3O4 nanoparticles, together or separately, 
and of their combination with background oral administration of the BPC (X ± s.e.). 
Control (6 Rats) 
Mn3O4-NPs  
(6 Rats) 
NiO-NPs  
(6 Rats) 
NiO-NPs +  
Mn3O4-NPs (6 Rats) 
NiO-NPs + Mn3O4-NPs  
and BPC (6 Rats) 
BPC  
(6 Rats) 
0.42 ± 0.00 0.51 ± 0.01 * 0.51 ± 0.01 * 0.50 ± 0.01 * 0.45 ± 0.01 *,+ 0.41 ± 0.01 
* statistically significant difference from the control group; + from the group given NiO-NPs + Mn3O4-NPs 
(without the BPC); (p < 0.05 by Student’s t-test with Bonferroni correction). 
3. Discussion 
Using intraperitoneal injections for modeling systemic intoxication, which in real conditions can be 
induced by long term inhalation exposure of workers needs some justification. It is well known that 
“nanoparticles deposit with high efficiency in the entire respiratory tract, from the head airways to the 
alveoli, due to diffusion” [26]. For instance, the widely used Human Respiratory Tract Model (HRTM) 
of the International Commission of Radiological Protection (ICRP) [27,28] predicts 100% total 
deposition of 0.001 μm (i.e., 1 nm) and ~90% for 0.01 μm (i.e., 10 nm) particles for a normal adult 
mouth breathing male human subject. However, there are many anatomical, functional and aerodynamic 
differences between humans and rodents which make one assume interspecies distinctions in regional 
particle deposition and thus in the kinetics of their elimination from the airways to the GIT and/or 
absorption. No wonder that the authors of a comprehensive review of nano-toxicological assessment 
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techniques [29] maintain that “rodents, the commonly used species for toxicology testing, are 
obligatory nose breathers and, therefore, not representative models for human respiratory inhalation 
exposure”. In other words, NP inhalation by laboratory rodents is not as ideal a model of real human 
exposures as it is often deemed to be. 
The intraperitoneal model permits one to circumvent these interspecies differences of inhaled NP 
deposition and is adequate enough when one wants to look into body distribution and elimination of 
NPs, and for organism’s reactions to NPs after they have penetrated into the blood from a primary 
deposit. Like any model (always a necessary simplification of a complicated system deliberately 
omitting some sub-systems and some material or informational flows and feedbacks), it has both 
drawbacks and virtues. Among the latter, one should take into consideration that dosing by injection is 
much more accurate and reliable as compared with the more “natural” experimental methods. This 
reason is crucial for experiments of comparative design like ours. Intraperitoneal modeling of 
subchronic intoxications is well known and recognized in general experimental toxicology. Moreover, 
it was used not only by us [1,2,4,6] but also by other researchers [30,31] just in experimental  
nano-toxicological studies. 
In this Section, we might first have discussed all the detected toxic effects of the studied NPs and 
then pass on to discussing the preventative efficacy of the bio-protective complex (BPC). However, 
although the toxicity attenuating action of this BPC is important as such, especially from the practical 
point of view, it is also a useful research tool. It helps to additionally verify the causality of this or that 
difference between the group exposed to the toxic impact and the control group, and to demonstrate 
that a difference is indeed due to this impact rather than to sampling errors. Despite the importance of 
the widely used statistical methods for null hypothesis testing, they always leave room for doubt. 
Meanwhile, there is a long established diagnostic approach in clinical medicine known as making a 
diagnosis ex juvantibus (that is making an inference about disease causation from its beneficial 
response to a specific treatment), which can be used in experimental toxicology as well. This approach 
was used by us for presenting our research on CuO-NPs toxicity [4], but it is not really quite new. For 
instance, it is fairly common to prove the mechanistic role of oxidative stress under different toxic 
impacts in vitro by reducing it with the help of antioxidants and free radical scavengers. 
For these reasons, we propose to discuss the toxic outcomes in parallel with the discussion of 
changes in them brought about by the background administration of anti-toxic bioprotectors. 
The results described in the previous Section provide evidence, first of all, that the subchronic IP 
exposure of rats to NPs of both metal oxides in the doses used caused the development of a moderately 
pronounced intoxication which did not lead to the death of the animals or even to a retarded weight 
gain. Nevertheless, this intoxication was clearly manifest not only through adverse changes in a great 
number of functional indices of the organism’s status but even through substantial morphological 
damage to the organs studied. 
When comparing the effects of NiO-NPs and Mn3O4-NPs, noteworthy is the prevailing similarity of 
the type of changes, tending, however, to be more pronounced under the effect of Mn3O4-NPs for the 
majority of the indices. 
At the same time, the reduction of the kidney mass and morphometric indices of nephrotoxicity 
(Table 4) were somewhat more marked in response to the action of NiO-NPs, which is likely to be 
associated with the predominantly renal route of nickel excretion (in contrast to the predominantly 
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hepato-biliary elimination of manganese). Indeed, the Thus, 24 h urinary excretion of nickel under 
exposure to NiO-NPs (Table 2) was 13 times higher than the same in control rats and 632 times higher 
than the respective value for manganese both in controls and under exposure to Mn3O4-NPs. Given 
such significant dependence of the chemical stress endured by kidneys in the process of these metals’ 
elimination on the kind of NPs rats were exposed to, one might predict even much more pronounced 
difference between indices of their nephrotoxicity than really observed. 
The functional and biochemical data summarized in Table 3 point to the protective efficacy of the 
BPC not only in relation to the changes in the eight effects listed in the previous Section, which proved 
to be statistically significantly weaker in the case of combined intoxication against the background 
BPC administration than for the same exposure without such bioprotection. An additional criterion of 
this efficacy is the fact that a value was no longer statistically significantly different from the control 
one for not only these but also a great number of other indices. 
Moreover, analysis based on a linear discriminant function with stepwise variable selection enabled 
us to create, using a set of seven indices (out of the ones that did not differ statistically significantly in 
pairwise comparison) [32], a decision rule that permitted to refer reliably (with from 75% to 100% 
correct classifications) an observation to one of the groups under comparison: controls, exposed to the 
combination of particles, or exposed to the same combination with background BPC administration. 
The squared Mahalanobis distance (which can be regarded as a measure of dissimilarity between 
groups) proved to be 10.1 between the “Controls” and the “Combined exposure without BPC”, and 
only 4.6 between the “Controls” and the “Combined exposure with the administration of the BPC”, 
being equal to 6.6 between the two exposed groups. In other words, even this small set of seemingly 
insignificant indices suggests that the group exposed to the NPs with the BPC being administered 
shifted closer to the control group, demonstrating less difference from the latter than from the group 
exposed to the NPs without BPC administration. 
Comparison of functional effects under separate and combined exposures to NiO-NPs and Mn3O4-NPs 
reveals their additivity or even synergism judging by some of indices but subadditivity judging by the 
others. Outside the nanotoxicological agenda, such complex characterization of different metals 
combined toxicity seems to be a general rule [3] but within it, this question is considered for the first 
time. Therefore, for an in-depth understanding of the type of combined toxicity of the NPs based on 
the above-mentioned data and on those discussed below, it was necessary to rely on its mathematical 
modeling which is considered by us elsewhere. 
It is worth specially noting that only exposures to Mn3O4-NPs, both alone and in combination with 
NiO-NPs, were associated with a substantially increased concentration of uric acid in the urine. The 
essential role of uric acid as a component of the organism’s antioxidant system is well known [33]. An 
experimental intoxication of rats with manganese demonstrated an increased uric acid content of the 
striatum, presumably associated with the activation of xanthine oxidase [34]. It is quite probable, 
however, that the effect of manganese on the uric acid balance in the organism is dependent on the 
level of exposure and/or the phase of intoxication. Indeed, the workers who were exposed to 
manganese for a long time were found to have a lowered, rather than elevated, concentration of uric 
acid in the urine in comparison with those who were not so exposed [35]. Also, it should not go 
unmentioned that, in our experiment, the concentration of uric acid in the blood serum of the rats was, 
unlike that in the urine, reduced significantly in equal extent in response to Mn3O4-NPs and NiO-NPs. 
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Comparing this fact with the decrease in the blood serum concentrations of reduced glutathione and 
two enzymes (catalase and, to a lesser degree, γ-glutamintransferase), also participating in antioxidant 
protection, we can assume that all these changes reflect an elevated expense of the antioxidant 
system’s reserves under the oxidative stress caused by both nano-metals. Although we find it difficult 
to explain the obvious inconsistency between the shifts of the uric acid content in the urine and blood, 
the association of both shifts with the intoxication is again corroborated by their absence in the group 
exposed to the combination of Mn3O4-NPs and NiO-NPs with the background antitoxic bio-protection. 
There is no serious doubt as to the specificity of the damaging action of manganese oxide NPs on 
the neurons of the striatum (in particular, of the caudate nucleus) and the hippocampus. This 
interpretation is highly plausible considering the well-known key role of the syndrome resembling 
Parkinson’s disease in the clinical presentation of chronic manganese intoxication in humans. For this 
reason, we attach special significance to the changes in neurons in these areas of the brain that we 
found in the rats exposed to Mn3O4-NPs alone or in combination with NiO-NPs (Figures 5–7, Table 6). 
Specifically, our microscopic study revealed clear signs of damage to the neuron bodies in both the 
caudate nucleus and the CA1 area of the hippocampus. In particular, we observed poor staining of the 
eosinophilic granulosity of the nuclei, disappearance of the nuclear membrane, and pycnosis of the 
nucleolus, which was often displaced towards the periphery of the nucleus or was absent. Whether 
these features may be interpreted as light microscopy signs of neuronal apoptosis or of other types of 
neuron’s toxic damage is difficult to decide without special tests (e.g., an immuno-histochemical 
detection of caspase 3) but we believe that such an interpretation is plausible enough. 
For these brain structures morphometry, we used the disappearance of the nucleolus as the most 
accurate and unbiased index and, on the other hand, a virtually normal appearance and location of the 
nucleolus. Both indices testified concurrently to: (a) high neurotoxicity of Mn3O4-NPs and, to the same 
degree, of the combination of Mn3O4-NPs + NiO-NPs; (b) much lower, if any, neurotoxicity of NiO-NPs 
acting separately; (c) dramatic alleviation of this crucial effect of combined neurotoxicity by background 
BPC administration. 
In the liver, the most remarkable intergroup difference was in the number of Kupffer cells (i.e., 
activated resident macrophages of this organ) which was statistically significantly increased only under 
the exposure to Mn3O4-NPs, both alone and combined with NiO-NPs. We had also observed this effect 
under subchronic IP exposures to iron oxide NPs [2], metallic silver, metallic gold [6], and copper 
oxide [4]. 
This activation of tissue macrophages may be related not only to the capturing of particles by them 
from the bloodstream. Indeed, judging from the EPR spectroscopy results, the NiO-NPs content of the 
liver was higher as compared with that for Mn3O4-NPs while only the latter induced a statistically 
significant increase in the Kupffer cells count. As is well known, however, resident macrophages play 
multiple roles in the process of apoptosis of an organ’s functional cells, engulfing, in particular, 
apoptotic bodies [36]. In the liver, it is just the Kupffer cells that play this important role [37]. Thus, 
Kupffer cell activation might serve as an indirect indicator of the metallic NPs’ hepatocytotoxic effect, 
which is indeed known to be associated with apoptosis [38]. The alleviation of this effect of NPs by 
background administration of bio-protectors reducing their toxicity (demonstrated by us in 
experiments with Ag-NPs and CuO-NPs as well) provides evidence in favor of such interpretation. We 
should qualify it, however, assuming that hepatocyte’s death under the impact of the studied NPs 
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might be not only of the apoptotic but also of the necrobiotic kind as is evidenced by the statistically 
significant increase in the proportion of akaryotic cells (Table 5). Moreover, this index of NP-induced 
necrosis of hepatocytes was the highest under the exposure to NiO-NPs, while it was just in this group 
that we did not observe any increase in the Kupffer cell count. This seeming discrepancy of the two 
effects under discussion might be a circumstantial evidence in favor of our assumption that the 
mechanisms of hepatocyte killing by Mn3O4-NPs and by NiO-NPs are somewhat different. 
It is of interest as well that the combined effect of these NPs on the Kupffer cell count is explicitly 
superadditive while that on akaryotic hepatocytes is rather subadditive. Anyway, both hepatic effects 
under consideration were reduced down to a statistically non-significant level with background BPC 
administration (Table 5). 
This attenuating influence of the BPC on the morphometric indices of liver damage can be 
juxtaposed with a reduction of the burden on the organ with at least one of the toxic metals (nickel), 
including in the form of NiO-NPs (Table 1, Figure 1). In the spleen too, a similar beneficial 
toxicokinetic effect of the BPC might be one of possible causes of the attenuation of this organ’s 
responses to the combined toxic impact (Table 5). In particular, the BPC decreased significantly 
accumulation of an iron-containing pigment (presumably, hemosiderin) probably associated with the 
capturing by the activated resident splenic macrophages of more rapidly aging erythrocytes from the 
bloodstream and with their enhanced disposal. This hypothesis may be substantiated by the fact that 
the BPC attenuated also the hemolytic anemia caused by combined toxic exposure (Table 3). As to a 
seemingly paradoxical decrease, under the toxic exposure, of the red pulp to the white pulp planimetric 
ratio, it was due not to decrease in the former but to increase in the latter, evidently, as a reaction of 
lymphoid tissue to metals toxicity. This hyperplasia of the white pulp was reflected by the increase in 
the spleen mass (Table 3) Anyway, a significant attenuation of all these shift against the background 
BPC administration suggests again that they were not chance findings but effects of the NPs toxicity. 
It should be noted, however, that we discovered but few such explicitly beneficial toxicokinetic 
effects of the BPC, and we have not found them even in the organs for which the attenuation of 
toxicodynamic effects under the influence of the same BPC causes no doubts. It is especially 
noteworthy in this respect that under combined toxic exposure the action of the BPC did not decrease 
(rather, increased a little) the manganese content of the rat’s brain but lowered sharply and statistically 
significantly the nickel content. Meanwhile, as follows from Table 7, the BPC substantially reduced 
morphological damage to the target brain structures of the rats under combined exposure, which 
damage in this experiment was most probably associated more with the neurotoxicity of manganese 
than with that of nickel. It should be noted, in this context, that we observed similar damage in the 
caudate nucleus under subchronic exposure to CuO-NPs [4] and that in that experiment as well a 
substantial attenuation of the effect under the influence of a BPC was not accompanied by a reduction 
in the copper content of the brain as a whole. 
We believe that this and other seeming contradictions between a high protective efficacy of the 
BPC in relation to the effects of toxic action and low (and even paradoxical) dependence of the 
accumulation of toxic metals in the organs on the same BPC point to the fact that beneficial 
toxicodynamic effects of bioprotectors are associated with various mechanisms (partly touched upon 
above in Section 2 when justifying the choice of bioprotectors), among which mechanisms a reduction 
in the tissue dose of metals is far from necessary being the key one. 
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Moreover, we found quite a long ago that in various metal intoxications this reduction is often not 
only, and not so much, the cause of attenuation of the toxic effect as the latter’s result [24]. In the 
present case, for example, the BPC could reduce the body burden and thus the retention of nickel in 
different organs because of the enhanced excretion of this metal with urine which, in is turn, might be 
due to the alleviation of the kidney damage. 
As is it has been already mentioned above, kidneys are the main organ of excretion for nickel 
(unlike manganese) and, in our experiment, the exposure to NiO-NPs caused a sharp increase in renal 
excretion of nickel while a similar exposure to Mn3O4-NPs did not result in a measurable increase in 
the excretion of manganese. At the same time, nickel excretion was significantly lower under exposure 
to the combination of the metals than to NiO-NPs alone, while manganese excretion, on the contrary, 
was significantly higher than under exposure to Mn3O4-NPs alone. These seeming contradictions can 
be hypothetically explained as follows. Toxic damage to the kidneys, greatest just under combined 
exposure, presumably reduced their ability to eliminate both metals. However, in relation to the renal 
excretion of manganese, another mechanism seems to have prevailed, the one associated with 
predominantly erythrocyte-bound transport of this metal by the blood. Admittedly, the accelerated ageing 
of erythrocytes under the effect of nickel [39] leading to their more extensive destruction, redistributes 
part of the manganese into the plasma, thus enabling the kidneys to eliminate it. Circumstantial 
evidence for the consistency of these hypotheses is that both seemingly contra-directional toxicokinetic 
effects of combined exposure to NiO-NPs + Mn3O4-NPs were attenuated by the BPC, which also 
reduced both the damage to the kidneys (Table 4) and the decrease in the erythrocytes count (Table 3). 
Earlier we demonstrated the absence of an unequivocal and easily interpreted conformity between 
toxicokinetic and toxicodynamic indices also for the effects of combined impact of two or three  
metals in the form of water-soluble salts, including the combination of KMnO4 + NiCl2 [22]. Such 
interpretation is even more difficult under a combined action of metallic nanoparticles because the 
toxicokinetics of the same metals in this case is controlled by considerably distinct toxicokinetic 
mechanisms for persisting NPs and for metal ions released by NPs’ dissolution, the balance of these 
mechanisms being different for NPs of different solubility. The outcome is such paradox as the 
substantial increase in the retention of total nickel in the liver due to the accompanying impact of 
manganese, (Table 1), and, in the same time, a decrease in the retention of nickel in the form of NiO-NPs 
in organs where its amount would be sufficient for measurement, i.e., again in the liver and in the 
spleen (Figure 1). 
The seemingly odd circumstance that we failed to find any accumulation of Mn3O4-NPs even in 
these organs as well as the fact that in all organs studied the total manganese accumulation was lower 
than total nickel accumulation can be explained by faster dissolution in vivo of manganese oxide 
nanoparticles compared with nickel oxide ones. This hypothesis was supported, in an additional model 
in vitro experiment, by a comparative assessment of the solubility of Mn3O4-NPs and NiO-NPs in 
sterile bovine blood serum. After 24 h dissolution, the serum concentration of Mn3O4-NPs reduced 5 
times while the concentration of NiO-NPs diminished by 7% only. The decay of EPR signal kinetics 
was fitted: for Mn3O4-NPs, by a two-exponential function with time constants τ1 = 20 ± 3 min and  
τ2 = 425 ± 100 min, while for NiO-NPs by a single exponential function with τ = 405 ± 70 min. 
Genotoxicity of many metallic nanoparticles was demonstrated by a lot of researchers although 
mostly in in vitro experiments on stable cell lines. In our previous studies we were able to demonstrate, 
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with the help of the RAPD test, a significant in vivo damage to the genomic DNA of target organs’ 
cells and of nucleated blood cells under subchronic exposures to silver NPs, gold NPs [6] and copper oxide 
NPs [4]. In the experiments with Ag-NPs and CuO-NPs we tested in parallel the same DNA-damaging 
effect in rats exposed to these NPs and given BPCs having a composition similar to that used in the 
present study (although differing in some details). We found that in both cases this effect was 
significantly alleviated. This experience permits us, as we believe, to consider the RAPD-test that in 
this study was performed only on blood cells (Table 7) as a “monitor” of the in vivo genotoxicity on 
the organism level of manganese and nickel NPs acting separately or in combination and of its 
alleviation by the BPC. 
By way of concluding the discussion of our results, we cannot avoid considering the issue of the 
statistically significant shifts in comparison with the control values that were observed for 6 functional 
indices in the group receiving BPC alone, namely: increase in the average volume of red blood cells, 
decrease in SDH activity in lymphocytes, and the concentrations of AST, ALT, uric acid and thyroxin 
in blood serum. The physiological or diagnostic importance of these shifts is hardly significant not 
only because their absolute values are not high but also because they appear to be occasional rather 
than systemic. Thus, the BPC did not change any other index of the red blood in non-exposed rats 
except for a small increase in the average volume of RBC; nor were reduced the levels of other blood 
serum enzymes but the just listed. 
However, it is even more important that comparison of the group administered the BPC in parallel 
to combined toxic exposure with the group exposed to the same combination without BPC 
administration shows that the discussed effects of the latter are essentially different. Indeed, such 
comparison reveals no influence of the BPC on the thyroxin content of the blood serum, while for the 
other above-mentioned five indices it had the opposite sign, bringing them closer to the control values, 
i.e., being explicitly beneficial. 
Thus, the expectation stated in Section 2 when justifying the composition and doses of the 
bioprotectors tested, namely that an additional intake of some biologically active micronutrients over 
the balanced food might be excessive for the organism living under normal conditions but is quite 
justified in the conditions of toxic stress caused by chronic exposure to the nanoparticles studied, has 
been confirmed. Aiming at an eventual controlled trial of this BPC on volunteers just in the conditions 
of such exposure [24], we believe there are all grounds to expect a high protective efficacy and not to 
be afraid of any side-effects of this BPC. 
4. Experimental Section 
The experiment was carried out on outbred white female rats from our own breeding colony with 
the initial body weight of 150 to 220 g, with minimum 12 animals in different exposed and control 
groups (the actual numbers of rats used for this or that post-exposure investigation are given in  
Tables 1–7). Rats were housed in conventional conditions, breathed unfiltered air, and were fed 
standard balanced food. The experiments were planned and implemented in accordance with the 
“International guiding principles for biomedical research involving animals” developed by the Council 
for International Organizations of Medical Sciences (1985) and were approved by the Ethics 
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Committee of the Ekaterinburg Medical Research Center Medical for Prophylaxis and Health 
Protection in Industrial Workers. 
For this experiment, we prepared suspensions of metal oxide nanoparticles by laser ablation of  
pure metal targets in water. A plate of pure nickel or manganese with a metal content of 99.9% was 
placed on the bottom of a shallow tray with deionized water. Metal ablation was performed using an 
Fmark-20RL laser material processing system (Laser Technology Center, St. Petersburg, Russia), 
based on ytterbium-doped pulsed fiber laser (pulse length 100 ns, repetition rate 21 kHz, wavelength 
1064 nm). The energy density was about 80 J/cm2. The target was irradiated in scanning mode with the 
rate of the laser spot at 270 mm/s. At the beginning, seven scanning cycles were used for preparation 
of the target surface. 
A scanning electron microscope (SEM), CrossBeam Workstation Auriga (Carl Zeiss, Jena, Germany), 
was used for the visualization of the nanoparticles. A Raman confocal microscope, Alpha 300 AR 
(WiTec, Ulm, Germany), was used for analysis of the NP composition. 
The concentration was increased to 0.5 mg/mL by partial evaporation of the primary suspensions 
for 5 h at 50 °C. The nanoparticles in both suspensions were of spherical shape (Figure 8). Their chemical 
composition was revealed by Raman Spectroscopy (Figures 9A and 10A). The average particle 
diameter (±s.d.) obtaineda by statistical processing of hundreds of scanning electron microscopy 
(SEM) images was 16.7 ± 8.2 nm for NiO-NPs and 18.4 ± 5.4 nm for Mn3O4-NPs. The distribution 
functions (Figures 9B and 10B) were symmetrical in both cases. 
  
Figure 8. SEM images of NiO (left) and Mn3O4 (right) nanoparticles in suspension 
obtained by scanning electron microscopy. 
 
Figure 9. Characteristics of nickel oxide NPs produced by laser ablation. (A) Raman 
spectrum; (B) size distribution function obtained by statistical processing of SEM NPs images. 
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Figure 10. Characteristics of manganese oxide nanoparticles produced by laser ablation. 
(A) Raman spectrum; (B) size distribution function obtained by statistical processing of 
SEM images of NPs. 
The absence of noticeable changes in the zeta potential as well as in the shape and position of the 
plasmon resonance peak 30 days after suspension preparation confirmed the high stability of the NiO-NPs 
suspension. The Mn3O4-NPs suspension was less stable, but disaggregation of nanoparticles was easily 
achieved by a short-run ultrasonication just prior to the injection. No chemical stabilizers were added 
to either of the suspensions. 
Each nanomaterial thus prepared was administered to the rats intraperitoneally (IP) 3 times a week 
(up to 18 injections) at a dose of 0.5 mg per rat (i.e., about 2.5 mg/kg) in 1 mL of the suspension. To 
avoid direct interactions between chemically different NPs resulting in their fast aggregation, the NiO-NPs 
and Mn3O4-NPs suspensions were drawn into different syringes and injected separately to the rats of 
the combined exposure group, one after another, at an interval of about 1 min. The rats of the groups 
exposed to NPs of either NiO-NPs or Mn3O4-NPs alone were additionally injected with the same 
volume of sterile deionized water (from the batch used for preparing the suspensions) by the same 
route, while the rats of the control group received only IP injections of this water. 
A special group of rats was injected with the same dosage of (NiO-NPs + Mn3O4-NPs) but with 
background administration of a bio-protective complex (BPC) described below, and still another group 
was given the same BPC plus IP injections of water. 
Immediately after the end of the exposure period, the following procedures were performed for  
all rats: 
 Weighing. 
 Estimation of the CNS ability for temporal summation of sub-threshold impulses—A variant of 
the withdrawal reflex and its facilitation by repeated electrical stimulations in an intact, 
conscious rat. 
 Recording of the number of head-dips into the holes of a hole-board (which is a simple but 
informative index of exploratory activity frequently used for studying the behavioral effects of 
toxicants and drugs). 
 Collection of daily urine for analysis of its output (diuresis), specific gravity (density), protein, 
total coproporhyrin, δ-aminolevulinic acid (δ-ALA), urea, uric acid, creatinine, and Ni and  
Mn contents. 
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 Then the rats were killed by decapitation and blood was collected by exsanguination. The liver, 
spleen, kidneys, and brain were weighed. The biochemical indices determined from the blood 
included reduced glutathione (GSH), total serum protein, albumin, globulin, bilirubin, ceruloplasmin, 
malonyldialdehyde (MDA), alkaline phosphatase, alanine- and asparate-transaminases (ALT, 
AST), catalase, gamma glutamyl transferase, SH-groups, urea, uric acid, creatinine, thyrotropic 
hormone of hypophysis, thyroxin, and triiodothyronine. For determining hemoglobin content, 
hematocrit, mean erythrocyte volume and for counting RBC, WBS and thrombocytes we used 
the MYTHIC-18 auto-hematology analyzer. Reticulocytes percentage was counted using the 
routine technique. Cytochemical determination of succinate dehydrogenase (SDH) activity in 
lymphocytes was based on the reduction of nitrotetrazolium violet to formasan, the number of 
granules of which in a cell is counted under immersion microscopy. 
All the clinical laboratory tests on blood and urine bar specially stipulated were performed using 
well-known techniques described in many manuals [40]. 
The statistical significance of the differences between the group arithmetic mean values was 
estimated using Student’s t test with Bonferroni correction for multiple comparisons, but the tables of 
results below do not specify it for the groups, comparing which is senseless at all. Specifically, we do 
not compare the group exposed to NiO-NPs + Mn3O4-NPs + the BPC with those exposed to either 
NiO-NPs or Mn3O4-NPs without the BPC; neither do we compare all three groups exposed to these 
NPs (separately or in combination) with the one given the BPC without any NPs. 
The total concentrations of the metals (Ni and Mn) in the samples of the liver, kidneys, spleen and 
brain were measured by the atomic emission spectroscopy (AES) method using an atomic emission 
spectrometer with inductively coupled plasma iCAP 6500 Duo (Thermo Scientific, Waltham, MA, 
USA). Samples of the freeze-dried homogenized tissue were subjected to acid ignition with the help of a 
MARS 5 microwave accelerated reaction system (Matthews, NC, USA). The NiO-NPs and Mn3O4-NPs 
NP contents of the samples of the same organs were revealed by the electron paramagnetic resonance 
(EPR) method using an electron paramagnetic resonance spectrometer EMX Plus (Bruker, Karlsruhe, 
Germany). The measurements of the freeze-dried homogenized tissue were done at room temperature. 
Liver, spleen, kidney, and brain tissue sections were prepared from four rats from each treated and 
control group for histological examination by the hematoxilin and eosin stain and, when necessary, 
PAS, Nissl or Perl’s stain. For morphometric characterization of these tissues we used the 
Avtandilov’s planimetric ocular grid and the image recognition programmed system CellSens 
(Olympus, Hamburg, Germany) [41]. 
4.1. Testing of the in Vivo Genotoxicity with the Random Amplification of Polymorphic DNA (RAPD) 
Test on Blood Nucleated Cells 
Totally, we analyzed 66 blood samples, each sample in three replications. The samples were 
collected into special vessels cooled to −80 °С. These were then promptly delivered in cryo-containers 
to a specialized laboratory. To isolate DNA from the cells, we used a GenElute (Sigma, St. Louis, MO, 
USA) set of reagents in accordance with the manufacturer’s guidelines for use. The DNA content of 
the samples was determined spectrophotometrically (Ultraspec 1100 pro; Amersham Biosciences Ltd.: 
Amersham, UK); then they were frozen and stored at −84 °С in a kelvinator (Sanyo Electric Co., Ltd.: 
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Moriguchi, Japan) till the beginning of the RAPD (Random Amplified Polymorphic DNA) test 
performed as described by us earlier [42]. The method is based on the fact that, unlike a fragmented 
DNA, which, in the agarose gel electrophoresis, forms the so-called comet tail, a non-fragmented DNA 
has a very low degree of migration and virtually stays in the same place (comet head), the degree of 
migration being directly related to the degree of DNA fragmentation. DNA amplification was carried 
out using specific primers and tritiated nucleotides. To characterize the degree of damage to DNA we 
used the “coefficient of fragmentation”, i.e., the ratio of total radioactivity of all tail fractions to that of 
the head. 
4.2. Choice of Bioprotectors 
Based on the literature dealing with the mechanisms of toxic action of Ni and Mn and on our 
experience in the successful testing of various bioprotectors against other intoxications [24], including 
those caused by nano-Ag [6] and nano-CuO [4], we chose the following substances for estimating their 
possible protective action against the combined subchronic intoxication with NiO-NPs and Mn3O4-NPs: 
(1) Glutamate as an effective cell membrane stabilizer acting through the intensification of ATP 
synthesis under exposure to the damaging action of various cytotoxic particles [6,43–45] and, at the 
same time, as one of the precursors of glutathione, which is a powerful cell protector against the 
oxidative stress, the latter being one of the key mechanisms of virtually all metallic NPs’ cytotoxicity 
and genotoxicity [5]. In addition to these non-specific and almost universal bio-protective effects of 
glutamate, we believed that its administration might specifically increase resistance to manganese 
neurotoxicity due to glutamate’s major role in transmitting excitatory signals in the mammalian central 
nervous system and thus involvement in most aspects of normal brain functioning. Indeed, although the 
mechanisms of manganese neurotoxicity are yet to be elucidated, it is widely maintained that manganese 
impairs the expression and function of the main glutamate transporters in astrocytes [46,47].  
We therefore supposed that additional glutamate supply to the cells would partly compensate for this 
adverse effect of manganese toxicity. 
(2) The other two glutathione precursors: glycine and cysteine (the latter in a highly active and 
metabolically well available form of N-acetylcysteine), taking into consideration both the general 
important role played by the oxidative stress as a mechanism of metallic NPs cytotoxicity and the 
experimental data demonstrating that glutathione deficiency potentiates manganese toxicity in the rat 
striatum and brainstem [48]. 
(3) Other components of the organism’s anti-oxidant system (vitamins А, Е, and С, and selenium). 
(4) ω-3 polyunsaturated fatty acids, whose intracellular derivatives are eicosanoids that activate 
DNA replication and thus play an important part in its repair, which was demonstrated by us earlier 
under exposure to various genotoxic agents (e.g., [4,6,42]). 
(5) Iodine, taking into consideration complex disturbances of the thyroid function caused by 
manganese intoxication [49]. 
(6) Pectin enterosorbent as an agent that prevents the re-absorption of toxic metals excreted into  
the intestines with bile (which, again, is of special importance for manganese as it is excreted 
predominantly by this route). 
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The doses and administration methods of these bio-protectors are given in Table 8. 
Table 8. Doses and the mode of administration of the bioprotectors tested in our experiment. 
Bioprotectors Estimated Dosage and the Mode of Administration
Apple pectin 1 g/kg (added to the fodder) 
Sodium glutamate 160 mg per rat (as a 1.5% drink instead of water) 
Glycine 12 mg per rat (added to the fodder) 
N-Acetylcysteine 30 mg per rat (added to the fodder) 
Vitamin C 4.4 mg per rat (added to the fodder) 
Vitamin E 0.84 mg per rat (added to the fodder) 
Selenium 4.0 mcg per rat (added to the fodder) 
Commercial fish oil rich in vitamin A 
and omega 3 rich PUFA 
1 drop per rat (sublingually) 
Potassium iodide 4.0 mcg per rat (added to the fodder) 
We gave glutamate to the rats as 1.5% solution instead of drinking water ad libitum. The “Amber 
Dew” (Ecco-Plus Ltd.: Zhukovskiy, Russia), a fish oil preparation rich in PUFA mainly of the ω-3 
group (24%), was administered through gavage at a dose of 1 mL per rat. The apple pectin 
enterosorbent (Promavtomatika Ltd.: Belgorod, Russia) was added to the rats’ fodder in a quantity 
corresponding to a dose ca. 1000 mg/kg body weight. Commercial preparations of iodide, amino acids 
and vitamins available as tablets were crushed and added to another portion of the fodder in quantities 
corresponding to recommended daily intake of these micronutrients for rats (where such recommendations 
were known only for humans, a recalculation to the rat’s nutritional requirement was made based on 
the species’ standard metabolism ratio). 
Taking into consideration that the standard balanced fodder presumably meets the normal 
nutritional requirements of a rat, we assumed that additional intake of the above-listed bioactive 
substances would meet the increased needs connected with the molecular mechanisms of metallic NPs 
toxicity. Nevertheless, it had to be checked whether or not such presumed overloading with them 
would evoke any unfavorable effects. That is why in our subchronic experiment one group of rats was 
administered the same BPC but was not exposed to any toxicant. 
5. Conclusions 
Our experiment has shown that a subchronic exposure of rats to spherical nanoparticles of nickel(II) 
and of manganese(II, III) oxide of similar size cause the development of moderately expressed 
subchronic intoxication, which in both cases is characterized by adverse changes in a great number of 
mostly the same functional indices and damage of essentially the same type to the microscopic 
structure of the internal organs. However, the majority of signs suggest that Mn3O4-NPs are more toxic 
than NiO-NPs in spite of the fact that the accumulation of manganese (both total and, especially, in the 
form of the NPs) in the organs rich in RES cells (liver and spleen) was substantially lower in response 
to the impact of Mn3O4-NPs than the accumulation of nickel in response to the impact of NiO-NPs. 
Quite probably, both the higher toxicity and the lower retention of the Mn3O4-NPs in the organism are 
connected with their higher solubility as compared with NiO-NPs. 
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At the same time, exposure to Mn3O4-NPs increases the total amount of manganese in the brain, and the 
effect of damage to the neurons of the caudate nucleus and the hippocampus caused by their action in a 
higher degree than by the action of NiO-NPs can be considered as toxicologically specific to manganese. 
The type of combined toxicity of Mn3O4-NPs and NiO-NPs is different for different indices 
(additivity, synergism, and subadditivity), and its identification deserves special mathematical analysis. 
On the whole, however, it should be stated that such combined exposure caused a no less pronounced 
overall picture of intoxication, including damage to the brain structures, than exposure to Mn3O4-NPs 
alone did. 
Substantial attenuation of almost all effects due to the combined exposure by the administration of a 
set of bioprotectors the actions of which are targeted at different hypothesized mechanisms of toxicity 
has promising prophylactic prospects but also presents theoretical interest, indirectly confirming both 
the causality of those effects and the mechanistic premises of their choice. 
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